Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

W John Smither


  • Chief Financial Officer at Arcutis Biotherapeutics Inc. (ARQT), 2020-03-04
  • Director at Principia Biopharma Inc. (PRNB), 2019-02-21
  • Chief Financial Officer at Sienna Biopharmaceuticals Inc. (SNNA), 2019-01-03
  • Director at Achaogen Inc (AKAO), 2018-06-07
  • Chief Financial Officer at Kythera Biopharmaceuticals Inc (KYTH), 2015-10-02
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KYTH $74.90 13,763 Officer 3,368 2015-09-24 Filing
KYTH $74.90 13,154 Officer 3,368 2015-09-24 Filing
KYTH $74.90 13,646 Officer 3,368 2015-09-23 Filing
KYTH $74.90 13,272 Officer 3,368 2015-09-23 Filing
KYTH $74.90 2,115 Officer 3,368 2015-09-22 Filing